Genbioma

Genbioma is redefining metabolic health through microbiome-based innovation for the nutraceutical and food industries. We are the creators of pA1c®HI, the first clinically validated postbiotic for glucose control, a natural, safe and highly stable ingredient that is reshaping the market. pA1c®HI stands out for its proven efficacy, full thermal stability (UHT, pasteurization) and versatile formulation, making it the perfect choice for next-generation supplements and functional foods. With clinical evidence in prediabetes, type 2 diabetes and obesity, it enables brands to differentiate with high-impact, science-backed metabolic health solutions. Powered by our proprietary development platform and a strong global industrial network, Genbioma accelerates the delivery of disruptive functional ingredients. We help brands lead the next wave of microbiome-driven cardiometabolic wellness.